# Risk: __Similar stability to SARS-CoV-1__ (PBN__Risk_2274)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskSource

* [van_doremalen_aerosol_2020](../Article/PBN__Article_21)

## Property: has_RiskName

Similar risk of virus transmission and environmental contamination as SARS-CoV-1.

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskTechnology

* [social distancing](../Technology/PBN__Technology_906)
* [isolation measures](../Technology/PBN__Technology_1855)

## Property: has_RiskOwner

* [governments](../Stakeholder/PBN__Stakeholder_47)
* [healthcare](../Stakeholder/PBN__Stakeholder_192)

## Property: has_RiskType

* [biological](../RiskType/PBN__RiskType_10)

## Property: has_RiskDescription

SARS-CoV-2 has similar stability to SARS-CoV-1, indicating that differences in epidemiology likely arise from other factors.

## Property: has_RiskISO_Purpose

* [Health and care](../RiskISO/PBN__RiskISO_Impact_3)

## Property: has_RiskMitigation

* [Implement strategies to control transmission, such as social distancing and isolation measures.](../RiskMitigation/PBN__RiskMitigation_2962)

